Chemo-immunotherapy Using Ibrutinib Plus Indoximod for Patients With Pediatric Brain Cancer
Conditions: Ependymoma; Medulloblastoma; Glioblastoma; Primitive Neuroectodermal Tumor (PNET) Interventions: Drug: Ibrutinib; Drug: Indoximod; Drug: Cyclophosphamide; Drug: Etoposide Sponsors: Theodore S. Johnson; Augusta University Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 3, 2021 Category: Research Source Type: clinical trials